Vanguard Fiduciary Trust
MGRX icon

Vanguard Fiduciary Trust’s Mangoceuticals MGRX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Hold
57,163
– – ﹤0.01% 3986
2026
Q1 		$20.6K Buy
+57,163
New +$27.4K ﹤0.01% 3947

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Vanguard Fiduciary Trust's MGRX Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Mangoceuticals (MGRX) position steady in Q2 2026 at 57,163 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3986.

Vanguard Fiduciary Trust first reported a position in MGRX in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Vanguard Fiduciary Trust held 57,163 shares of Mangoceuticals worth $21.7K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Mangoceuticals share count unchanged in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3986 holding.
  • Vanguard Fiduciary Trust first reported a position in Mangoceuticals in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.